Electromed, Inc.
AMEX:ELMDMedical - Devices
+$0.43 today
- Market cap
- $191.27M
- Beta
- 0.52
- P/E (TTM)
- 30.5
- EPS (TTM)
- $1.23
Volume 0.05M
Average 0.06M
ELMD Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Electromed, Inc.AMEX: ELMD
Capital Expenditures · Q3 FY2026 · quarter ended Mar 2026
Capital expenditures turns negative
Q3 FY2026 capital expenditures was -$147K, compared with $237K a year earlier. Trailing-twelve-month capital expenditures was -$304K. Over 3 fiscal years it compounded at -41.5% a year.
Context
- Capital expenditures amounted to 0.5% of revenue in FY2025, down 0.2 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly capital expenditures holds near -$147K or moves back toward the trailing-twelve-month quarterly average of -$76K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (306K) USD
- Year-over-year change
- +22.5%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | (306K) | +22.5% |
| FY2024 | 2024-06-30 | (395K) | +77.0% |
| FY2023 | 2023-06-30 | (1.72M) | -12.5% |
| FY2022 | 2022-06-30 | (1.53M) | -240.4% |
| FY2021 | 2021-06-30 | (448K) | — |
Capital Expenditures vs competitors
How ELMD compares with its peers on the latest reported figures
- ELMD's LTM Mar 2026 capital expenditures of $304K is the 5th largest of the 6 companies compared; the peer median is $31.21M.
- Its year-over-year change of +284.8% is the highest of 6, against a peer median of +17.5%.
- Capital expenditures amounts to 0.4% of revenue for ELMD, versus a peer median of 4.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $408.02M | +30.0% | -0.8% | 14.3% | |
| LTM Jun 2026 | $267.46M | +188.0% | +5.3% | 4.7% | |
| LTM Mar 2026 | $31.21M | -33.9% | +20.4% | 10.9% | |
| LTM Mar 2026 | $2.84M | +17.5% | +7.4% | 0.8% | |
| LTM Mar 2026 | $304K | +284.8% | -41.5% | 0.4% | |
| LTM Mar 2026 | $160K | -87.7% | -30.0% | 0.2% | |
| Peer median (excluding ELMD) | $31.21M | +17.5% | +5.3% | 4.7% | |
Competitors are the stored peer set for ELMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | 2.36M | 2.31M | 3.17M | 5.15M | 7.54M |
| Depreciation & Amortization | 610K | 628K | 613K | 841K | 1.17M |
| Deferred Income Tax | (294K) | (489K) | (43K) | (571K) | (310K) |
| Stock-Based Compensation | 1.02M | 976K | 708K | 1.69M | 3.06M |
| Change in Working Capital | (625K) | (4.11M) | (3.13M) | 1.96M | (277K) |
| Accounts Receivables | (3.58M) | (3.91M) | (3.28M) | 565K | (1.64M) |
| Inventory | 971K | (1.07M) | (1.03M) | 459K | 175K |
| Accounts Payables | 214K | 2.17M | 420K | (1.21M) | 1.65M |
| Other Working Capital | 1.77M | (1.29M) | 763K | 2.14M | (458K) |
| Other Non-Cash Items | 0 | 0 | 0 | 0 | 212K |
| Operating Cash Flow | 3.08M | (686K) | 1.32M | 9.07M | 11.39M |
| Capital Expenditures | (448K) | (1.53M) | (1.72M) | (395K) | (306K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (161K) | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (448K) | (1.53M) | (1.72M) | (395K) | (306K) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (1.12M) | (1.45M) | (153K) | (275K) | (10M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (95K) | (77K) | (227K) | 311K | (1.88M) |
| Financing Cash Flow | (1.22M) | (1.53M) | (380K) | 36K | (11.88M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 1.41M | (3.74M) | (781K) | 8.71M | (793K) |
| Free Cash Flow | 2.63M | (2.21M) | (401K) | 8.67M | 11.09M |
Electromed, Inc.
AMEX:ELMD
Intrinsic Alpha fair value
Locked
Current Price
$23.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.